価格表
在庫・価格 : 2025年04月27日 03時10分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-Fractalkine, Mouse, Goat-Poly データシート※最新のデータシートでない場合があります |
AF472 |
RSDアールアンドディー システムズ R&D Systems, Inc. |
100 μg | ¥104,000 |
無 (未発注) |
追加 |
在庫・価格 : 2025年04月27日 03時10分 現在
Anti-Fractalkine, Mouse, Goat-Poly
- 商品コード:AF472
- メーカー:RSD
- 包装:100μg
- 価格: ¥104,000
- 在庫:無(未発注)
使用文献
- No.: 1
-
文献情報:
Labrada L et al. Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. J. Virol. 2002 Nov;76(22):11688
Labrada L et al
2002/01/01
-
備考:
Species: Mouse, Application: IHC Paraffin-embedded, Sample type: Whole Tissue -
参照:
- No.: 2
-
文献情報:
Lesnik P et al. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 2003 Feb;111(3):333-40
Lesnik P et al
2003/01/01
-
備考:
Application: In vivo, Sample Type: N/A -
参照:
- No.: 3
-
文献情報:
Ueha S et al. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects. J. Leukoc. Biol. 2007 Jan;81(1):176-85
Ueha S et al
2007/01/01
-
備考:
Application: IHC Fresh/Frozen, Sample Type: Whole Tissue -
参照:
- No.: 4
-
文献情報:
Ren T et al. Down-regulation of surface fractalkine by RNA interference in B16 melanoma reduced tumor growth in mice. Biochem. Biophys. Res. Commun. 2007 Dec;364(4):978-84
Ren T et al
2007/01/01
-
備考:
Species: Mouse, Application: Flow Cytometry, IHC Fresh, IHC Paraffin-embedded, Western Blot, Sample type: Whole Cells, Whole Tissue, Cell Lysates -
参照:
- No.: 5
-
文献情報:
Liu P et al. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler. Thromb. Vasc. Biol. 2008 Feb;28(2):243-50
Liu P et al
2008/01/01
-
備考:
Species: Mouse, Application: IHC Frozen, Sample type: Whole Tissue -
参照:
- No.: 6
-
文献情報:
Ishida Y et al. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J. Immunol. 2008 Jan;180(1):569-79
Ishida Y et al
2008/01/01
-
備考:
Species: Mouse, Application: IHC, IHC Paraffin-embedded, Sample type: Whole Tissue -
参照:
- No.: 7
-
文献情報:
Ishida Y et al. Essential involvement of CX3CR1-mediated signals in the bactericidal host defense during septic peritonitis. J. Immunol. 2008 Sep;181(6):4208-18
Ishida Y et al
2008/01/01
-
備考:
Species: Mouse, Application: IHC Fresh, Whole Cells -
参照:
- No.: 8
-
文献情報:
Eberlein J et al. Comprehensive assessment of chemokine expression profiles by flow cytometry. J. Clin. Invest. 2010 Mar;120(3):907-23
Eberlein J et al
2010/01/01
-
備考:
Application: Flow Cytometry, Sample Type: Whole Cells -
参照:
- No.: 9
-
文献情報:
Staniland AA et al. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice. J. Neurochem. 2010 Aug;114(4):1143-57
Staniland AA et al
2010/01/01
-
備考:
Application: IHC Frozen,Western Blot, Sample Type: Spinal Cord Extract,Whole Tissue -
参照:
- No.: 10
-
文献情報:
Noda M et al. Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J. Biol. Chem. 2011 Jan;286(3):2308-19
Noda M et al
2011/01/01
-
備考:
Application: Neutralization, Sample Type: Whole Cells -
参照:
- No.: 11
-
文献情報:
Morimura S et al. Interaction between CX3CL1 and CX3CR1 regulates vasculitis induced by immune complex deposition. Am. J. Pathol. 2013 May;182(5):1640-7
Morimura S et al
2013/01/01
-
備考:
Application: IHC Unspecified, Sample Type: Whole Tissue -
参照:
- No.: 12
-
文献情報:
Wang H et al. P2RX7 sensitizes Mac-1/ICAM-1-dependent leukocyte-endothelial adhesion and promotes neurovascular injury during septic encephalopathy. Cell Res. 2015 Jun;25(6):674-90
Wang H et al
2015/01/01
-
備考:
Application: In vivo, Sample Type: In Vivo -
参照:
- No.: 13
-
文献情報:
Goto Y et al. CXCR4(+) CD45(-) Cells are Niche Forming for Osteoclastogenesis via the SDF-1, CXCL7, and CX3CL1 Signaling Pathways in Bone Marrow. Stem Cells 2016 Jun;
Goto Y et al
2016/01/01
-
備考:
Application: Neutralization, Sample Type: Whole Cells -
参照: